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Dear Sir:
Nonbacterial thrombotic endocarditis (NBTE), a form of endo-
carditis in which noninfectious vegetations are deposited on 
cardiac valves, is a cause of stroke. NBTE is frequently related 
to malignancies and hypercoagulable conditions.1,2 Since previ-
ous pathological investigations of NBTE have been based on 
postmortem studies of cardiac valve vegetations,1,3 the histo-
logical features of intracranial arterial thrombi in NBTE remain 
unknown. We present the histological features of thrombi, 
which were retrieved by using a stent retriever, in a patient 
with stroke and NBTE.
A 55-year-old man was admitted for multiple cerebral and 
cerebellar infarctions (Supplementary Figure 1A). He had no 
relevant medical history. The findings of 12-lead electrocardi-
ography and continuous electrocardiographic monitoring, 
during his stay in the stroke unit, were normal. Blood chemis-
try, coagulation, and autoimmunity test results were within the 
normal ranges, except for an elevated level of D-dimer 
(7,251 mg/mL) (Supplementary Figure 2). Transesophageal 
echocardiography showed echogenic masses on the anterome-
dial leaflet of mitral valve and the non-coronary cusp of aortic 
valve, which were compatible with NBTE (Figure 1A). Positron 
emission tomography-computed tomography (CT) and abdomi-
nopelvic CT showed multiple metastatic lymph nodes with 
F-18 fluorodeoxyglucose uptake in the portacaval, aortocaval, 
and para-aortic areas. Laparoscopic lymph node biopsy showed 
moderately differentiated metastatic adenocarcinoma. The pa-
tient was diagnosed with primary unknown cancer. He was 
treated with intravenous heparin and advised to take rivarox-
aban following discharge (15 mg bid) as he had concomitant 
pulmonary embolism. He developed small multiple scattered 
infarctions in the bilateral cerebellar and cerebral hemispheres 
(Supplementary Figure 1B), 4 days after discharge. Subcutane-
ous enoxaparin (60 mg bid) was administered. However, 6 days 
later, he developed sudden weakness on his left side. CT angi-
ography showed occlusion of the right proximal middle cere-
bral artery. Endovascular thrombectomy was performed with 
Solitaire (ev3, Irvine, CA, USA). The artery was successfully re-
canalized after five passes, but developed a large infarction 
(Supplementary Figure 1C). The retrieved pieces of thrombi 
were whitish and rubbery (Figure 1B). We performed hematox-
ylin-eosin and immunohistochemical staining for platelets, fi-
brin/fibrinogen, red blood cells, and neutrophils. Details of the 
staining methods are described in the Details of the staining 
methods in the supplementary data (Supplementary Method 1). 
Histologic examinations demonstrated that the entire throm-
bus area comprised platelets interwoven with thin fibrin 
strands. The fibrins also lined the edge of the thrombus. There 
were few neutrophils and red blood cells (Figure 1C-G).
The thrombi in this case were rich in platelets. To our knowl-
edge, this is the first report demonstrating the histopathologi-
cal features of intracranial thrombi in NBTE. Previous patho-
logical examination of cardiac valve vegetations in NBTE 
showed platelet thrombi interwoven with fibrin strands, with-
out leukocytes,1,3 The histological features of thrombi retrieved 
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in the current case were similar to those of the cardiac valve 
vegetations in previous reports of NBTE, which suggested that 
the thrombi were embolized from the vegetation in the mitral 
or aortic valve. Vegetations in NBTE were observed on leaflets 
of the mitral or aortic valves where a high-flow condition ex-
ists.2 Red thrombi are known to be produced in low-flow con-
ditions, whereas white thrombi are produced in high-flow con-
ditions.4 Thus, high-shear stress might have contributed to the 
formation of platelet-rich thrombi in NBTE.
The patient described in this report developed stroke three 
times within 1 month. Furthermore, the last two attacks re-
curred during anticoagulation therapy. In the past, intravenous 
or subcutaneous heparin has been empirically recommended 
for stroke prevention in NBTE.5 Anticoagulants are usually ef-
fective in preventing the formation of slow-flow-related red 
thrombi. In contrast, antiplatelet agents are effective against 
high-flow-related white thrombi. Experiences similar to the 
present case are limited. However, the histological features of 
platelet-rich thrombi, occurrence of vegetation at high-flow 
locations, and ineffective anticoagulation for stroke prevention 
highlighted whether anticoagulation should be the treatment 
of choice for stroke prevention in patients with NBTE. Anti-
platelet agents may be an alternative treatment for stroke pre-
vention, at least in cancer-associated NBTE.
Supplementary materials
Supplementary materials related to this article can be found 
online at https://doi.org/10.5853/jos.2017.00696.
Figure 1. (A) Transesophageal echocardiogram showing a 0.6×0.5-cm echogenic mass on the anteromedial leaflet of the mitral valve (arrow). (B) Retrieved 
thrombi. (C) Hematoxylin-eosin staining of the thrombus. (D–G) Immunohistochemical analyses with antibodies against CD42b, fibrinogen, myeloperoxidase, 
and glycophorin A, to visualize platelets, fibrin/fibrinogen, neutrophils, and red blood cells (RBCs), respectively. Positive signals were indicated by the develop-
ment of a brown color. Abundant platelets were seen in the entire thrombus (D); fibrinogen/fibrin appeared at the edge or as thin strands within the thrombus 
(E); neutrophils were hardly visible (F); and RBCs were present (arrowheads) (G). 
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Supplementary Method 1. Immunohistochemical study.
Immunohistochemical analysis was performed on paraffin tis-
sue sections, which were cut at a thickness of 4 μm. IHC- 
TekTM epitope retrieval solution and steamer (IHC world, Wood-
stock, MD, USA) were used for antigen retrieval of CD42b epit-
opes. After cooling from the heat, sections were treated with 
0.075% glycine in phosphate-buffered saline (PBS) for 10 min-
utes, and blotto (Tris-buffered saline containing 1% horse se-
rum and 5% skim milk) was added thereafter. Following the 
blotto incubation, the sections were incubated with the prima-
ry antibodies for 2 hours at 37°C (for myeloperoxidase), or 
overnight at 4°C (for CD42b, fibrinogen, and glycophorin A). 
The following primary antibodies were used in this study: rab-
bit monoclonal anti-CD42b (1:100, ab134087; Abcam, Cam-
bridge, UK), rabbit polyclonal anti-Fibrinogen (1:200, ab34269; 
Abcam), rabbit monoclonal anti-Glycophorin A (1:400, 
ab129024; Abcam), and mouse monoclonal anti-myeloperoxi-
dase (1:200, MAB3174; R&D systems, Inc., Minneapolis, MN, 
USA). Sections with blotto lacking a primary antibody were 
used as a negative control. Next, sections were incubated with 
secondary antibodies for 30 minutes at 37°C, followed by 0.3% 
hydrogen peroxide in methyl alcohol for 20 minutes. The sec-
tions were then subjected to a 2-minute tap water wash, before 
being treated with an avidin-biotin-horseradish peroxidase 
complex (Vector Laboratories Ltd., Peterborough, Cam-
bridgeshire, UK) for 30 minutes to amplify the signals. The sig-
nals were visualized by 3,3′-diaminobenzidine solution (PBS 
containing 0.05% 3,3′-diaminobenzidinetetrahydrochloride hy-
drate and 0.1% hydrogen peroxide). After counterstaining with 
hematoxylin, the slides were mounted with Permount mounting 
medium (Fisher Scientific, Fair lawn, NJ, USA). Sections were 
viewed using Axio Imager D2 microscope and Axio Vision soft-
ware (Carl Zeiss MicroImaging GmbH, Jena, Germany).
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Supplementary Figure 1. Diffusion-weighted imaging (DWI) following the first attack (A) and second attack (B), and computed tomography (CT) imaging 
following the third attack (C). Initial DWI demonstrated a medium-sized infarction involving the left posterior cerebral artery, and many small infarctions in 
the bilateral cerebellar and cerebral hemispheres (A). Follow-up DWI after recurrence showed a similar pattern of infarctions (multiple small infarctions in the 
bilateral cerebellar and cerebral hemispheres and small-to medium sized infarction in the right cerebellum (B). The CT scan after the third attack showed a 
large infarction in the right middle cerebral artery territory (C).  
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Supplementary Figure 2. Serial changes in the level of D-dimer and 
treatment modality. NBTE, nonbacterial thrombotic endocarditis; IV, intra-
venous; SQ, subcutaneous.
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